logo
Bausch + Lomb Returning enVista® Intraocular Lenses to Market Following Voluntary Recall

Bausch + Lomb Returning enVista® Intraocular Lenses to Market Following Voluntary Recall

National Post24-04-2025

Article content
VAUGHAN, Ontario — Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced it has identified the event that led to its recent voluntary recall of intraocular lenses (IOLs) on the enVista platform. Now that the cause and affected lots have been confirmed, the company will return these models to market.
Article content
Article content
'We voluntarily recalled these lenses because patient safety dictates every decision we make,' said Brent Saunders, chairman and CEO, Bausch + Lomb. 'We wouldn't bring them back without full confidence in the enVista safety profile, which has been established over years and hundreds of thousands of implants.'
Article content
Investigation Results
Article content
After a thorough investigation in collaboration with a globally recognized toxic anterior segment syndrome (TASS) expert and an advisory group of nearly 30 top cataract surgeons including American Society of Cataract and Refractive Surgery leadership, the company determined that the issue stemmed from raw material used in certain lots that was delivered by a different vendor. The tight correlation between the lots in question and reported TASS cases is clear, as highlighted in the recall timeline.
Article content
Bausch + Lomb continues to share its findings with the U.S. Food & Drug Administration and other regulatory authorities.
Article content
In response to the investigation, Bausch + Lomb has implemented enhanced inspection protocols for IOLs, as well as more explicit standards for how the monomers that make up its lenses are prepared by vendors.
Article content
With these new processes in place, Bausch + Lomb has returned to full production of all enVista IOLs. In the following weeks the company will return to full market supply in the U.S.; timing for market reentry in other countries will be determined on a case-by-case basis in collaboration with health authorities.
Article content
See a message from Saunders to customers and TASS fact sheet for additional information. Bausch + Lomb will discuss financial impacts of the voluntary recall on its April 30 first-quarter earnings call.
Article content
About Bausch + Lomb
Article content
Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from birth through every phase of life. Its comprehensive portfolio of approximately 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint with approximately 13,500 employees and a presence in approximately 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario, with corporate offices in Bridgewater, New Jersey. For more information, visit www.bausch.com and connect with us on Facebook, Instagram, LinkedIn, X and YouTube.
Article content
Forward-looking Statements
This news release may contain forward-looking statements, which may generally be identified by the use of the words 'anticipates,' 'hopes,' 'expects,' 'intends,' 'plans,' 'should,' 'could,' 'would,' 'will,' 'may,' 'believes,' 'estimates,' 'potential,' 'target,' or 'continue' and variations or similar expressions. Forward-looking statements include statements regarding the recent voluntary recall of certain of our enVista IOLs, including the anticipated timing of market reentry and return to full market supply in the U.S. and other countries. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, the risks and uncertainties discussed in Bausch + Lomb's filings with the U.S. Securities and Exchange Commission and the Canadian Securities Administrators (including the company's Annual Report on Form 10-K for the year ended Dec. 31, 2024 and its most recent quarterly filings). They also include risks relating to the voluntary recall of certain of our enVista® IOL products, including the timing of market reentry and return to full market supply, the success of the enhanced inspection protocols and more explicit standards for third party suppliers we have implemented for IOLs and any additional actions that may be taken by the company and/or regulatory authorities with respect to the recall or as part of the return to market of these products. Readers are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof. Bausch + Lomb undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this news release or to reflect actual outcomes, unless required by law.
Article content
Article content
Article content
Article content
Contacts
Article content
Media Contact:
Caryn Marshall
caryn.marshall@bausch.com
(908) 493-1381
Article content
Article content

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Should You Buy Nio Stock Right Now?
Should You Buy Nio Stock Right Now?

Globe and Mail

time20 minutes ago

  • Globe and Mail

Should You Buy Nio Stock Right Now?

Nio (NYSE: NIO) is reporting an increase in deliveries and vehicle margins. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » *Stock prices used were the afternoon prices of June 6, 2025. The video was published on June 8, 2025. Should you invest $1,000 in Nio right now? Before you buy stock in Nio, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Nio wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $669,517!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $868,615!* Now, it's worth noting Stock Advisor 's total average return is792% — a market-crushing outperformance compared to173%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of June 9, 2025 Parkev Tatevosian, CFA has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool.

S&P/TSX composite edges lower in late-morning trading, U.S. stocks mixed
S&P/TSX composite edges lower in late-morning trading, U.S. stocks mixed

Winnipeg Free Press

time2 hours ago

  • Winnipeg Free Press

S&P/TSX composite edges lower in late-morning trading, U.S. stocks mixed

TORONTO – Canada's main stock index edged lower in late-morning trading, weighed down by losses in the base metal and technology sectors, while U.S. stock markets were mixed. The S&P/TSX composite index was down 10.32 points at 26,365.48. In New York, the Dow Jones industrial average was down 11.02 points at 42,750.74. The S&P 500 index was up 1.56 points at 6,007.44, while the Nasdaq composite was down 8.57 points at 19,582.67. The Canadian dollar traded for 73.11 cents US compared with 73.08 cents US on Monday. The July crude oil contract was up 84 cents US at US$66.13 per barrel and the July natural gas contract was down eight cents US at US$3.55 per mmBTU. The August gold contract was down US$8.20 at US$3,346.70 an ounce and the July copper contract was down two cents US at US$4.91 a pound. Monday Mornings The latest local business news and a lookahead to the coming week. This report by The Canadian Press was first published June 10, 2025. Companies in this story: (TSX:GSPTSE, TSX:CADUSD)

S&P/TSX composite edges lower in late-morning trading, U.S. stocks mixed
S&P/TSX composite edges lower in late-morning trading, U.S. stocks mixed

CTV News

time2 hours ago

  • CTV News

S&P/TSX composite edges lower in late-morning trading, U.S. stocks mixed

People stand in front of the New York Stock Exchange in New York, Monday, April 7, 2025. (AP Photo/Seth Wenig) TORONTO — Canada's main stock index edged lower in late-morning trading, weighed down by losses in the base metal and technology sectors, while U.S. stock markets were mixed. The S&P/TSX composite index was down 10.32 points at 26,365.48. In New York, the Dow Jones industrial average was down 11.02 points at 42,750.74. The S&P 500 index was up 1.56 points at 6,007.44, while the Nasdaq composite was down 8.57 points at 19,582.67. The Canadian dollar traded for 73.11 cents US compared with 73.08 cents US on Monday. The July crude oil contract was up 84 cents US at US$66.13 per barrel and the July natural gas contract was down eight cents US at US$3.55 per mmBTU. The August gold contract was down US$8.20 at US$3,346.70 an ounce and the July copper contract was down two cents US at US$4.91 a pound. This report by The Canadian Press was first published June 10, 2025.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store